More
    Guided Solutions - Connecting Talent With Innovation/div>

    Second Heart Assist’s Whisper device has successful case studies

    Second Heart Assist announced successful case studies in South America with its Whisper catheter-delivered heart assist device. Dr. Adrian Ebner, head of the cardiovascular...

    Tivic completes enrolment in nerve stim trial

    Tivic Health Systems completed enrollment in a study for its vagus nerve stimulation (VNS) device. The study, conducted by The Feinstein Institute of Bioelectronic Medicine,...

    Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer

    Aethlon Medical has enroled the first patient in its Australian clinical trial evaluating the safety, feasibility, and optimal dosing of the Hemopurifier device in...

    Vivasure sees success in absorbable large-bore vessel device trial

    Irish absorbable tech company, Vivasure Medical, has announced results from a US Investigational Device Exemption (IDE) PATCH pivotal trial finding that its fully absorbable...

    CytexOrtho gets FDA approval for first-in-human trial of absorbable hip implants

    CytexOrtho today said it has approval from the FDA to start a Phase 1 clinical trial evaluating the safety and efficacy of its absorbable...

    Positive data for Cardiawave’s ultrasound tech that treats calcified aortic stenosis

    Cardiawave said its device for the treatment of severe symptomatic calcific aortic stenosis (CAS) met the primary endpoint in a pivotal study. The investigational...

    Sonablate enrols first patient in incompetent vein ablation clinical trial

    Sonablate announced the first patient enrolment in its HIFIVE U.S. clinical trial, which is testing high-intensity focused ultrasound (HIFU) for the noninvasive treatment of...

    BlueWind Medical reports positive data for tibial neuromod

    BlueWind Medical shared two-year data from the OASIS pivotal study of its implantable tibial neuromodulation (iTNM) system. Park City, Utah-based BlueWind said investigators presented...

    Corvia Medical has positive data for atrial shunt

    Corvia Medical announced three-year positive results from its clinical trial of its Corvia Atrial Shunt. The REDUCE LAP-HF randomized trial evaluated the safety and efficacy...

    Latest articles